Abstract
Vibrio cholerae O1 can cause life threatening diarrheal disease if left untreated. T cells can play critical roles in inducing B cell mediated immunity. As the mechanism of T cell dependent B cell maturation is not well established, we hypothesized that a specific population of T (follicular helper T, Tfh)) cells, are involved in B cell maturation following cholera. We found flowcytometrically that V. cholerae infection induces significant increases in circulating Tfh cells expressing B cell maturation associated protein CD40L early in disease. The increased Tfh cells expressing CD40L recognize cholera toxin most prominently, with lessened responses to V. cholerae membrane preparation (MP) and Vibrio cholerae cytolysin (VCC). We further showed that early induction of Tfh cells and CD40L was associated with later memory B cell responses to same antigens. Lastly, we demonstrated in vitro that Tfh cells isolated after cholera can stimulate class switching of co-cultured, isolated B cells from patients with cholera, leading to production of the more durable IgG antibody isotype colorimetrically. These studies were conducted on circulating Tfh cells; future studies will be directed at examining role of Tfh cells during cholera directly in gut mucosa of biopsied samples, at the single cell level if feasible.
Keywords: Follicular helper T cells, cholera, CXCR5, CD40L, B cells
1. Introduction
Cholera is a life threatening diarrheal disease. It is estimated that 3–5 million cases and 100,000 deaths occur globally every year [1]. Vibrio cholerae O1, the causative agent of cholera, produces cholera toxin (CT), Vibrio cholerae cytolysin (VCC), a variety of membrane-associated proteins, and the toxin-coregulated pilus A (TcpA), all involved in immunogenicity and pathogenicity [2, 3]. CT is a T cell dependent protein antigen that induces salt and water loss in the intestine resulting in profuse diarrhea, the major cause of dehydration and death [4] . Natural infection induces long-lasting CT-specific IgG producing memory B cells [4]. Such T cell dependent protein antigens can induce anamnestic memory B cell responses upon re-exposure, while T cell independent antigens like lipopolysaccharide (LPS) and the O-specific polysaccharide it contains fail to produce such durable responses after V. cholerae infection [4]. In addition to memory B cells that develop in response to V. cholerae protein antigens after infection, memory helper T cell responses to protein antigens also develop after cholera by day 7, prior to initiation of memory B cell responses to the same antigens; in contrast, memory helper T cell responses are not seen to LPS [3, 4].
Among T cells, Tfh are a subpopulation of CD4+ cells that are found in the secondary lymphoid organs as well as peripheral blood [5], express CXCR5 on their cell surface, and following stimulation by a cognate antigen, migrate into the B cell zones of lymphoid organs, mediated through CXCR5-CXCL13 crosstalk [6, 7]. There, Tfh cells interact with B cells that present the cognate antigen, with the help of major histocompatibility complex class II (MHCII) on their cell surface to be recognized by the T cell receptor (TCR); this recognition is facilitated by the interaction of CD40L on the surface of the activated Tfh and CD40 on the surface of the antigen-presenting B cell [8]. This contact dependent interaction, plus the secretion of cytokines, including IL-21 and IL-4 by the Tfh cell, helps to trigger the formation of germinal centers (GC). The CD40L-CD40 interaction is essential for formation of the germinal center and its maintenance in the secondary lymphoid organs [9]. In addition, this bi-directional interaction of Tfh-GC B cells facilitates the survival of those specific GC B cells. The Tfh-B cell interaction then leads to further B cell maturation, including isotype switching and somatic hypermutation by inducing activation-induced cytidine deaminase in B cells. This leads to either the production of mature plasma cells secreting high affinity, antigen-specific antibodies or the production of antigen-specific memory B cells [10, 11]. The role of Tfh cells, including expression of co-stimulatory molecules, has not been studied in cholera patients, and whether this same interaction leads to B cell activation and maturation in this mucosal infection is not known. We performed the current study to investigate these potential interactions.
2. Materials and methods
2.1. Study subjects and overview
Patients with symptoms of severe dehydration were admitted to the International Centre for Diarrheal Diseases Research, Bangladesh (icddr,b), Dhaka hospital. Patients’ stool was collected, and V. cholerae O1 infection was confirmed by dark field microscopy and by culture on selective taurocholate-tellurite gelatin agar media described elsewhere [12]. The serogroup and serotype of the infecting V. cholerae O1 strains were determined by agglutination test with anti-O1, anti-Ogawa and anti-Inaba specific monoclonal antibodies [13, 14]. Patients confirmed to have V. cholerae O1 infection (n=34) were enrolled following informed consent, and blood was collected acutely during infection (2nd day of hospitalization), during early convalescence (7th day after hospitalization) and late in the convalescent period (30th day after hospitalization). Patients were excluded from this study if co-infected with other enteric pathogens or parasites. The study was approved by Ethical and Research Review Committees of the International Centre for Diarrhoeal Disease Research, Dhaka, Bangladesh (icddr,b) and the Institutional Review Board of Massachusetts General Hospital.
2.2. Separation of peripheral blood mononuclear cells (PBMCs) and detection of CD40L expressing follicular helper T cells
Heparinized venous blood was collected in Becton-Dickinson (BD) vacutainer tubes and diluted with an equal volume of phosphate buffered saline (PBS, 10 mM, pH ~7.2). Diluted blood was carefully loaded on Ficoll-Isopaque (Pharmacia, Uppsala, Sweden) without disturbing the Ficoll layer, and then centrifuged at 700 g for 30 minutes at 20°C. After centrifugation, PBMCs were collected from the top of the Ficoll layer, washed and counted with a haemocytometer, and cell viability was assessed using trypan blue dye [15]. Separated PBMCs were incubated with anti CD3-PE Texas Red (Invitrogen, CA), anti CD4-Amcyan, anti CXCR5-Alexa-Fluor-488, and anti CD40L-APC-eFluor700 (BD Bioscience, San Jose, CA) fluorochrome-tagged antibodies. After 45 min of incubation in the dark at 4°C, extra fluorochrome was washed out with PBS supplemented with 2% fetal bovine serum (FBS) (HyClone, Logan, UT), the labeled cells diluted to the desired volume and then cell counts acquired with a FACSAriaIII instrument (BD Bioscience, San Jose, CA) and the FACSDiva software program. We analyzed the acquired data with FlowJo software (TreeStar, Inc., OR), separating the lymphocyte population depending on side and forward scattered light. Lymphocytes were then identified by gating on the CD3-positive population, followed by the CD4-positive population within the CD3-positive cells. Tfh cells were selected by CXCR5 expression on the cell surface of CD4-positive cells, and the Tfh population was selected using CD40L expression. The results are expressed as percentages.
2.3. Antigens used for short-term culture and CD40L expression, memory B cell enumeration, and depleted Tfh cell and B cell co-culture
Membrane preparation (MP), V. cholerae cytolysin (VCC), and cholera holotoxin containing the G33D variant of the B subunit (mCT) were used in this study. VCC (a gift from Kalyan K. Banerjee) monomer was produced from a nonclinical V. cholerae O1 strain that is biochemically and immunologically similar to V. cholerae O1 [16]. MP was prepared from V. cholerae O1 El Tor strain N16961 grown in AKI medium and the most abundant proteins were characterized by mass spectrometry [3, 17]. mCT (a gift from Randall K Holmes) has less binding affinity to eukaryotic cell surface ganglioside (GM1) due to an aspartic acid substitution by glycine on the B subunit, and is a less toxic variant of wild type cholera toxin (CT), useful in cell culture conditions [18]. VCC was used at a concentration of 2.5ng/ml. MP and G33D mCT were used at a concentration of 10µg/ml. We also used phytohaemagglutinin (PHA) (Remel, USA) as a positive control at 1µg/ml and media only as a negative control in cell stimulations in culture. In addition, recombinant cholera toxin B subunit (rCTB, a gift from Ann-Mari Svennerholm) was used for enumeration of antigen-specific memory B cells in the peripheral blood and in enzyme-linked immunosorbent assay (ELISA). Staphylococcal Enterotoxin B from Staphylococcus aureus (SEB) (Sigma, USA) was used as a positive control for co-culture of depleted Tfh cells and B cells, as done previously [5, 19].
2.4. Whole blood stimulation by FASCIA
We used Flow cytometric Assay of Specific Cell-mediated Immune responses in the Activated whole blood (FASCIA) to measure cellular proliferation in response to antigenic stimulation as previously described [3, 20, 21]. In brief, we collected whole blood in a lithium-heparinized vacutainer tube and diluted it to a ratio of 1:8 in Dulbecco modified Eagle medium (Gibco, NY) supplemented with 1% gentamicin, 1% mercaptoethanol, and 10% heat-inactivated fetal calf serum. We added 100ul of stimulating antigen, control antigen, or additional medium to each tube of 400ul of diluted blood in a 5 ml polystyrene tube. After 6 hours of in vitro stimulation in a humidified atmosphere with 5% CO2 at 37°C, cells were centrifuged and the supernatant was discarded. Whole blood was stained with anti-CD3-PE Texas Red (Invitrogen, CA), anti-CD4-Amcyan, anti-CXCR5-AF488, and anti-CD40L-APC eFluor700, monoclonal antibodies (BD Bioscience, San Jose, CA). Red blood cells were lysed with ammonium chloride solution containing potassium chloride and EDTA, and the remaining cells were centrifuged, washed and fixed with BD stabilizing fixative (BD Bioscience, San Jose, CA). Cell counts were acquired for 4 min by FACS Aria III and FACS Diva software (BD Bioscience). Acquired cell counts were analyzed using FlowJo (San Jose, CA). The magnitude of stimulation is expressed as the ratio of lymphocyte count expressing a certain protein on their cell surface with antigenic stimulation to the count without stimulation [21, 22]. The ratio is referred to as a stimulation index (SI). An SI value equal to “1” indicates that stimulation is equal in samples with or without a V. cholerae antigen, and more than “1” indicates V. cholerae antigen-specific stimulation. Lymphocytes were gated and counted depending on forward and side scattering characteristics. CD3+ cells were gated from lymphocytes and CD4+ cells were gated from CD3+ cells. Tfh cells were counted from CD4+ cells based on surface expression of CXCR5 on cell surface. CD40L expressing cells from the Tfh cell pool were analyzed.
2.5. Enzyme-linked immunosorbent spot (ELISPOT) assay to measure memory B cells
Memory B cells were measured by the ELISPOT assay described previously [23, 24]; this assay is optimized for stimulating differentiation of memory B cells into terminal, spot producing antibody secreting cells (ASCs). In brief, PBMCs were seeded (5×105 cells/well) in cell culture plates (BD Biosciences, San Jose, CA) with Roswell Park Memorial Institute medium (RPMI 1640, Gibco, Carlsbad, CA) and 10% FBS (HyClone, Logan, UT). Cells were stimulated with a cocktail of B cell mitogens containing 6 µg/ml CpG oligonucleotide (Operon, Huntsville, AL), a 1/100,000 dilution of crude pokeweed mitogen extract, and a 1/10,000 dilution of fixed Staphylococcus aureus Cowan (Sigma, St. Louis, MO). Plates were incubated at 37°C in 5% CO2 for 6 days. The cells were harvested, washed and was transferred onto nitrocellulose membrane-bottom plates (MSHAN-4550; Millipore, Bedford, MA) for 5 hours. The plates were coated previously with GM1 ganglioside (3 nmol/ml) overnight followed by rCTB (2.5 µg/ml), or with 5 µg/ml affinity-purified goat anti-human immunoglobulin (Jackson Immunology Research, West Grove, PA), or 2.5 µg/ml keyhole limpet hemocyanin as a negative control (Pierce Biotechnology, Rockford, IL). Each coating was followed by blocking with RPMI 1640 containing 10% FBS. After incubation, cells were washed out and horseradish peroxidase-conjugated goat anti-human IgA (Southern Biotech, USA) and alkaline phosphatase conjugated goat anti-human IgG (Southern Biotech, USA) were added. Following an overnight incubation at 4°C, plates were developed with 3-amino-9-ethyl carbazole and 5-bromo-4-chloro-3-indolyl-phosphate/Nitro blue tetrazolium for developing IgA and IgG spots. The spots were counted and results were expressed as the percentage of antigen-specific memory B cells out of the total isotype-specific memory B cells.
2.6. Co-culture of B cells and T follicular helper cells and ELISA measurement of total IgG production after co-culture
We largely followed a previously published procedure [5], with the exception that the co-cultures contained V. cholerae antigens for Tfh stimulation, with SEB as a positive control and media only as a negative control. PBMCs were separated by Ficoll-isopaque at day 7 after hospitalization and stained with anti-CD3-PE Texas Red, anti-CD4 Amcyan, anti-CD45R0 PE, anti- CXCR5-Alexa Flour 488, and anti-CD19-PerCP-Cy 5.5 and kept in the dark for 45 min at 4ºC. Then, the cells were washed with PBS 2% FBS to remove any unbound fluorochrome tagged antibody, passed through a 40μm cell strainer (BD) and diluted with PBS supplemented with 2% FBS to the desired concentration for sorting approximately 10 million cells per milliliter of buffer. CD19+ B cells, CD3+CD4+CD45R0+CXCR5+ memory Tfh cells (Tfh+) and CD3+CD4+CD45R0+CXCR5- memory cells (Tfh-) were sorted with a FACS AriaIII sorter and collected in three different 1% BSA pre-coated 5 ml polystyrene tubes (BD Falcon). After sorting, the separated cells were centrifuged and diluted to the desired volume. Sorted cell types were rerun to check the purity of the sorted cells; the percentage of purity was more than 98 percent. Sorted B cells (50,000 cells) were co-cultured with Tfh+ (50,000 cells) or Tfh- (50,000 cells) cells with antigenic stimulation for seven days in a humidified 5% CO2 incubator at 37°C. After seven days of co-culture, culture supernatants were collected and stored at −80°C to measure secreted IgG.
ELISA was used to measure the total secreted IgG from co-cultured supernatants [23]. In brief, a 96-well polystyrene plate (Nunc F) was coated with 5 µg/ml affinity-purified goat anti-human immunoglobulin (Jackson Immunology Research, West Grove, PA). Culture supernatant or ChromPure Human IgG molecule (Jackson Immunology Research, West Grove, PA) was applied and incubated for 90 minutes, followed by the addition of horseradish peroxidase-conjugated secondary antibodies to human IgG (Jackson Immunoresearch, USA). The plate was developed with ortho-phenylene diamine (Sigma, St. Louis, MO) in 0.1 M sodium citrate buffer (pH 4.5) and 0.1% hydrogen peroxide. The developed color was read using a microplate reader (Eon). Sample concentrations were determined by comparing to the known concentrations of pure IgG.
2.7. Statistical analysis
We used Graphpad Prism 5.0 for statistical analyses and to generate figures. We compared data using paired t-tests; the Wilcoxon signed-rank test was used to measure the responses of each patient on different days. We used Pearson’s correlation to assess the relationship between T and B cell responses. All reported P values are two tailed with 95% confidence intervals. P≤ 0.05 is considered as statistically significant.
3. Results
3.1. Study population
A total of 34 adult patients were recruited in this study. Demographic and clinical features of these study patients by age, sex, blood group and duration of diarrhea at presentation are shown in Table 1. Sample size in each experiment varied and was restricted by the allowed small volume of blood obtained from each participant. The enrollment of cholera patients in each group followed the progression of the experiments and generation of data, which then informed the investigators decision for the next experimental step. Twenty samples were analyzed for the determination of frequency of circulating Tfh cells and CD40L expressing Tfh cells after infection (Fig. 1), 18 were analyzed for evaluation of antigen-specific memory T cell responses (Fig. 2), 10 were used for the correlation analysis (Fig. 3) and 11 for the depletion and co-culture experiments (Fig. 4).
Table 1.
Characteristics | Patients |
---|---|
Number of study participants | 34 |
Median age in years (25th, 75th percentile) | 35 (29.8, 40.3) |
Gender, female (%) | 12 (35.3) |
Mean (SD) duration of diarrhea, hours | 30.7 (56.1) |
Blood group (%) | |
A | 25.8 |
B | 45.2 |
O | 25.8 |
AB | 3.2 |
3.2. Frequency of Tfh cells and CD40L expressing Tfh cells after onset of cholera
Whole blood was diluted and stained with anti-CD3, -CD4, -CXCR5 and -CD40L antibodies, and the resulting populations were counted by flow cytometry (Supplementary Fig. 1). The percentage of Tfh cells in peripheral blood was significantly increased at day 7 (15.3±1.1) following V. cholerae infection compared to day 2 (11.5±0.8) (P<0.0001) and waning by day 30 (13.8±0.9); however, the level remained elevated above baseline (Fig. 1A). CD40L-expressing Tfh cells were also significantly elevated at day 7 (P=0.01) and day 30 (P=0.05) following infection compared to day 2 (Fig. 1B). The expression of CD40L- expressing Tfh at day 30 did not decrease compared to day 7.
3.3. Antigen-specific Tfh cell proliferation and B cell maturity associated protein CD40L expression
Whole blood was obtained on day 2, day 7 and day 30 after infection, and diluted and stimulated with V. cholerae antigens: mCT, MP, or VCC for 6 hours, or unstimulated. The Stimulation Index (SI) (the ratio of cell number after stimulation with an antigen to cell number without stimulation) was calculated for each antigen. mCT-specific Tfh cells were significantly increased at day 7 after infection compared to day 2 (P=0.04, Fig. 2). mCT-specific Tfh cells that express CD40L were also significantly elevated following infection (P=0.02). The SI for MP and VCC antigen showed similar trends but did not reach statistical significance.
3.4. Antigen-specific Tfh cells and CD40L-expressing Tfh cells in the circulation on day 7 are correlated with subsequent antigen-specific IgA and IgG producing memory B cells on day 30 following cholera
mCT-specific Tfh and CD40L expressing Tfh cells were identified by FASCIA on day 7 of infection as above, and rCTB-specific IgA and IgG-secreting memory B cells were evaluated by ELISPOT on day 30 following infection in the same patients, and the results examined for correlation. Tfh cells specific for mCT on day 7 following infection correlated with IgG secreting memory B cells specific for rCTB on day 30 (Pearson r= 0.6, P=0.04, Fig. 3); a similar trend that did not reach statistical significance was seen for IgA secreting memory B cells on day 30. mCT-specific CD40L expressing Tfh cells on day 7 also correlated with IgA (Pearson r= 0.7, P=0.02) and IgG (Pearson r= 0.7, P=0.01) secreting rCTB-specific memory B cells on day 30 following infection.
3.5. Depletion of memory Tfh cells reduces the amount of IgG secretion by autologous B cells into culture supernatant following an in vitro co-culture of cells recovered from peripheral blood of cholera patients
B cells and Tfh cells were sorted from the peripheral blood of cholera patients (n=11) by flow cytometry. Sorted B cells (CD19+ cells) were co-cultured with sorted memory Tfh cells (CD3+CD4+CD45R0+CXCR5+ cells) and V. cholerae specific antigenic stimulation; these cells secreted a significant amount of IgG in the presence of MP or mCT, compared to B cells co-cultured with a fraction depleted in Tfh cells (CD3+CD4+CD45R0+CXCR5- cells) (Fig. 4). In comparison, without antigenic stimulation, B cells did not produce a significant amount of IgG in the presence of Tfh cells compared to depleted Tfh cells.
4. Discussion
Infection with V. cholerae produces protective immunity and induces antigen-specific IgG antibodies and IgG memory B cells to protein antigens such as CT that persist at least one year after V. cholerae infection [4, 25]. In addition, an oral cholera vaccine containing added rCTB has been shown to elicit an antigen-specific IgG immune response to CTB comparable to natural infection [23]. Both natural infection and existing vaccines with protein components induce B cells to produce and secrete durable, class-switched IgG antigen-specific antibodies. However, these durable and avid class-switched antibodies are only seen in response to protein antigens and are not observed for a non-protein antigen such as LPS [15]. This suggests that following V. cholerae infection, maturation of a repertoire of B cells specific for T cell dependent antigens could rely on interaction with a certain population of helper T cells [26]. However, the mechanism of this T cell dependent B cell maturation in a mucosal infection such as cholera is not fully defined. Here, we have shown that natural infection with V. cholerae induces antigen-specific Tfh cell proliferation and expression of CD40L, and that these Tfh cells then provide antigen-specific help for B cell maturation in the form of class switched antibody secretion and development of antigen-specific memory B cell responses to the same antigens in peripheral blood. Lastly, in an in vitro system, B cells co-cultured with Tfh cells recovered from cholera patients resulted in increased production of class switched IgG antibodies after culture with V. cholerae specific antigens. This suggests that Tfh cells are important in regulating B cell proliferation and maturation in this mucosal infection, leading to class switching and likely somatic hypermutation, as seen in other infections [24, 27–30].
In normal physiologic conditions, naïve T cells migrate from the thymus to the CCL19- and CCL21- rich region of a secondary lymphoid organ utilizing chemokine receptor CCR7, where they surveil for foreign antigens [31]. After interacting with antigen presenting cells, these naïve T cells become a heterogeneous population of antigen primed T cells that includes CXCR5- expressing follicular helper T cells (Tfh), which migrate to the B cell zone of the lymphoid tissue via interaction with CXCL13 [32, 33]. The proper spatial and temporal contact-dependent interaction between an antigen-primed Tfh cell expressing CD40L and CD40 expressing B cells in the T cell-B cell border of a secondary lymphoid organ is necessary for maturation of those B cells, including class switching of antibody production [10, 32, 34, 35]. Without proper help either by direct contact and/or cytokine production from Tfh cells, B cells do not undergo either class switching or somatic hypermutation to produce higher avidity IgA and IgG isotype antibodies [36, 37].
Whether similar events occur in lymphoid tissues of gastrointestinal mucosa or the draining lymph nodes following mucosal infection is not well defined. Here, we assayed peripheral blood of cholera patients in Bangladesh for circulating Tfh cells and their subsequent effect on antigen-specific B cell events following a mucosal infection caused by V. cholerae. Measuring these events in the circulation assumes that a small portion of the antigen-specific Tfh cells stimulated and active in GC follicles in lymphoid tissues migrate into, and can be assayed in peripheral blood, as shown by others [5, 19, 38]. We found that Tfh cells are upregulated in the circulation on day 7 after V. cholerae infection, and express higher amounts of the surface B cell maturation associated marker CD40L. This suggests that similar events are taking place in the GC of secondary lymphoid tissues after cholera. Previous groups have shown that CD40L is critical for GC development and maintenance [39], proliferation and maintenance of highly proapoptotic B cells within GC [9], and for plasma cell formation [40]. We have previously shown that CT-specific plasmablasts also peak in the circulation at day 7 after infection, at the same time as the circulating (and presumably lymphoid tissue-associated) Tfh cells expressing CD40L peak [41]. The fraction of CD40L expressing Tfh cells in the circulation may underestimate the fraction of these cells in GC of secondary lymphoid tissues. However, obtaining direct samples of secondary lymphoid tissues from cholera-infected patients in vivo to examine this correlation is challenging from a human study standpoint.
We demonstrated that the expanded, circulating Tfh cells at day 7 after infection with increased expression of CD40L are V. cholerae antigen-specific, particularly to the highly immunogenic G33D mutant of cholera toxin. We have previously shown a more durable memory B cell response to CT than to the T cell independent antigen LPS, suggesting that the interaction of Tfh cells expressing CD40L with cognate B cells orchestrates this more durable memory B response to CT in cholera patients [4]. A membrane preparation (MP) of V. cholerae was less effective in inducing Tfh cell proliferation and CD40L expression compared to mCT, which is consistent with our previous findings [22]. One possible explanation for this might be the heterogeneous mixture of proteins in MP, such that the quantity of each individual protein might not overcome a threshold level of T cell interaction with cognate B cells. This might be addressed by purifying and testing the more abundant proteins from MP, such as outer membrane protein U (OmpU). Although VCC has been previously shown to be immunogenic following cholera [3], we found here that VCC was less effective at stimulating Tfh cell proliferation and CD40L expression. A mutant form of VCC with lessened cytotoxicity may better assess the immunogenicity of VCC in this cellular proliferation assay. Earlier we reported after oral cholera vaccination, with or without recombinant cholera toxin B subunit, participants did not achieve equivalent protection compared to natural V. cholerae infection. The particular mechanisms of protective immunity to natural cholera are still poorly understood, and a detailed understanding of antibody and memory responses to natural cholera needs to be established. However, to improve our understanding of the repertoire and function of the antibody response to cholera in humans, monoclonal antibody generation from single B-cells obtained from cholera patients and vaccinated volunteers may have implications for future cholera vaccination efforts, and may increase our understanding of long term memory in relation to protection [42].
A previous study showed that naïve T cells take approximately 3 to 4 days to enter the B cell zone of lymphoid tissues following expression of CXCR5 on their surface starting at 36 hours [43]; naïve T cells need to accumulate sufficient CXCR5 to overcome signals from CCR7 that retain these cells in the T cell zone [32]. Therefore, most antigen-activated Tfh cells are in proximity to cognate B cells in the B cell region of GC around day 7 following infection. This timing is consistent with our previous findings that the T cell response on day 7 after cholera vaccination correlates with later B cell events in vaccine recipients [22].
A recent elegant study by Cardeno et al., published while this manuscript was being finalized, examined circulating Tfh cells in adults following oral vaccination with an inactivated ETEC vaccine [19], and the relationship of these circulating Tfh cells and B cell events. Although they found a small increase in overall CXCR5-expressing Tfh cells in the circulation 7 days after vaccination, they found a larger increase in the fraction of these Tfh cells expressing the activation marker ICOS; this is similar to our result of CD40L expression on circulating Tfh cells after cholera. Cardeno et al. [19] showed that circulating Tfh cells after ETEC vaccination express increased amounts of PD1 and β7, and produced increased IL-21 after stimulation. ETEC vaccination also led to an increased number of plasmablasts in the circulation on day 7 after vaccination, and the majority of these expressed IgA and β7, consistent with mucosal homing. In this study [19], there was a correlation of the fold rise of circulating activated Tfh cells in the circulation on day 7 and the fold rise in circulating IgA plasmablasts on day 7.
To directly model the effect of the circulating, antigen-specific Tfh cells on B cell maturation in our study, we used short term in vitro co-culture of Tfh cells and isolated B cells from cholera patients 7 days following infection. We showed that co-culture of CXCR5+, CD40L expressing Tfh cells with autologous B cells in the presence of V. cholerae antigens stimulated production of IgG antibodies in culture supernatants, while depletion of the Tfh cells from the pool of circulating T cells resulted in a significantly lower amount of IgG antibody production. A previous study by another group utilized co-culture of circulating B cells with CXCR5+ T cells from patients with the autoimmune disease juvenile dermatomyositis [5] and showed increased production of IgG and IgA antibodies in culture supernatants compared to co-culture of B cells with CXCR5-depleted T cells. Cardeno et al. [19] similarly isolated circulating Tfh cells and B cells following ETEC vaccination and showed that in vitro co-culture produced an increased frequency of IgA secreting plasmablasts differentiated from the B cells in the culture, increased amounts of total IgA and IgG secreted into culture supernatants, and increased IgA in culture supernatant specific for the B subunit of ETEC heat-labile enterotoxin from the vaccine. Of note, the two previous studies [5, 19] utilized the superantigen SEB in the co-culture experiments to stimulate the Tfh cells in vitro. We also used SEB as a positive control, but also showed that cholera-specific antigens could be utilized for antigenic stimulation as well, as opposed to a superantigen. Because freshly isolated PBMCs had been used for the Tfh depletion experiment, we could not repeat the measurements for each patient but rather repeated the measurements using different patients for verification of our results.
Cardeno et al. [19] also examined patients undergoing ETEC revaccination 1–2 years later to show a correlation between the fold rise of ICOS+, circulating Tfh cells on day 7 post primary vaccination, and the fold rise of IgA responses in circulating, mucosal antibody-secreting cells to ETEC antigens following revaccination 1–2 years later. We similarly found a correlation between CD40L expressing Tfh cells circulating on day 7 following cholera, and IgA and IgG memory B cell responses to rCTB on day 30 following infection. Both these observations are consistent with a model whereby Tfh cells in gut-associated lymphoid tissues induce B cells to mature to class switched IgA and IgG antibody producing plasma cells, as well as IgA and IgG memory B cells that are then found in the circulation following cholera [23]. Assessment of memory B cell responses at later time of points after V. cholerae infection are important to exploring our proposed model and were beyond the scope of this study.
Recently, Holmgren et al. summarized novel approaches to correlate early human mucosal immune responses with subsequent protection following mucosal vaccination, which include the investigation of gut-originating antibody-secreting cells (ASCs), memory B cells and Tfh cells from samples of peripheral blood during their recirculation from lymphoid tissues [44]. A previous report, however, suggests that in the absence of cognate interactions, the function of CD4 Tfh cells in GC of Peyer patches, as opposed to other lymphoid tissues, is not clear [45]. To better understand the role of Tfh cells in immune responses in cholera patients, further investigation including single cell studies from gut biopsies at the site of V. cholerae replication may be needed.
Our study and the previous work of others [5, 19] are consistent with a model in which activated Tfh cells in lymphoid tissues interact with B cells following mucosal infection or vaccination to stimulate affinity maturation and differentiation of antigen-specific plasmablasts and memory B cells, and that these events are important in development of mucosal memory to T cell dependent antigens. However, the protective immune response following cholera appears to be directed against the the O-specific polysaccharide component of LPS [46]; how mucosal memory develops to this T cell independent antigen is not yet clear, and also requires further study.
Supplementary Material
Acknowledgements
This work was supported by the International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b). This study was also supported by grants from the National Institutes of Health, including grants from the National Institute of Allergy and Infectious Diseases (AI106878 [E.T.R. and F.Q.] and AI058935 [S.B.C., E.T.R., and F.Q.], AI103055 [J.B.H. and F.Q], R01 AI130378 (T.R.B) and K08 AI123494 [A.A.W.], as well as the Fogarty International Center (Training Grant in Vaccine Development and Public Health; TW005572 [T.R.B., and R.R.]) and Emerging Global Leader Award; K43 TW010362 [T.R.B.]). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. We are also grateful to the Governments of Bangladesh, Canada, Sweden and the UK for providing core/unrestricted support.
Footnotes
Conflict of interest statement: None of the authors report any conflict of interest for the work reported here.
References
- [1].WHO. Cholera. Weekly epidemiological record 2012;87:289–304.22905370 [Google Scholar]
- [2].Herrington DA, Hall RH, Losonsky G, Mekalanos JJ, Taylor RK, Levine MM. Toxin, toxin-coregulated pili, and the toxR regulon are essential for Vibrio cholerae pathogenesis in humans. J Exp Med 1988;168:1487–92. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [3].Weil AA, Arifuzzaman M, Bhuiyan TR, LaRocque RC, Harris AM, Kendall EA, et al. Memory T-cell responses to Vibrio cholerae O1 infection. Infect Immun 2009;77:5090–6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [4].Harris AM, Bhuiyan MS, Chowdhury F, Khan AI, Hossain A, Kendall EA, et al. Antigen-specific memory B-cell responses to Vibrio cholerae O1 infection in Bangladesh. Infect Immun 2009;77:3850–6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [5].Morita R, Schmitt N, Bentebibel SE, Ranganathan R, Bourdery L, Zurawski G, et al. Human blood CXCR5(+)CD4(+) T cells are counterparts of T follicular cells and contain specific subsets that differentially support antibody secretion. Immunity 2011;34:108–21. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [6].Haynes NM, Allen CD, Lesley R, Ansel KM, Killeen N, Cyster JG. Role of CXCR5 and CCR7 in follicular Th cell positioning and appearance of a programmed cell death gene-1high germinal center-associated subpopulation. J Immunol 2007;179:5099–108. [DOI] [PubMed] [Google Scholar]
- [7].Johnston RJ, Poholek AC, DiToro D, Yusuf I, Eto D, Barnett B, et al. Bcl6 and Blimp-1 are reciprocal and antagonistic regulators of T follicular helper cell differentiation. Science 2009;325:1006–10. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [8].McHeyzer-Williams LJ, Pelletier N, Mark L, Fazilleau N, McHeyzer-Williams MG. Follicular helper T cells as cognate regulators of B cell immunity. Curr Opin Immunol 2009;21:266–73. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [9].Takahashi Y, Dutta PR, Cerasoli DM, Kelsoe G. In situ studies of the primary immune response to (4-hydroxy-3-nitrophenyl)acetyl. V. Affinity maturation develops in two stages of clonal selection. J Exp Med 1998;187:885–95. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [10].Crotty S. Follicular helper CD4 T cells (TFH). Annu Rev Immunol 2011;29:621–63. [DOI] [PubMed] [Google Scholar]
- [11].Good-Jacobson KL, Shlomchik MJ. Plasticity and heterogeneity in the generation of memory B cells and long-lived plasma cells: the influence of germinal center interactions and dynamics. J Immunol 2010;185:3117–25. [DOI] [PubMed] [Google Scholar]
- [12].Monsur KA. A highly selective gelatin-taurocholate-tellurite medium for the isolation of Vibrio cholerae. Trans R Soc Trop Med Hyg 1961;55:440–2. [DOI] [PubMed] [Google Scholar]
- [13].Qadri F, Azim T, Chowdhury A, Hossain J, Sack RB, Albert MJ. Production, characterization, and application of monoclonal antibodies to Vibrio cholerae O139 synonym Bengal. Clin Diagn Lab Immunol 1994;1:51–4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [14].Rahman M, Sack DA, Mahmood S, Hossain A. Rapid diagnosis of cholera by coagglutination test using 4-h fecal enrichment cultures. J Clin Microbiol 1987;25:2204–6. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [15].Alam MM, Arifuzzaman M, Ahmad SM, Hosen MI, Rahman MA, Rashu R, et al. Study of avidity of antigen-specific antibody as a means of understanding development of long-term immunological memory after Vibrio cholerae O1 infection. Clin Vaccine Immunol 2013;20:17–23. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [16].Yamamoto K, Ichinose Y, Nakasone N, Tanabe M, Nagahama M, Sakurai J, et al. Identity of hemolysins produced by Vibrio cholerae non-O1 and V. cholerae O1, biotype El Tor. Infect Immun 1986;51:927–31. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [17].Iwanaga M, Yamamoto K. New medium for the production of cholera toxin by Vibrio cholerae O1 biotype El Tor. J Clin Microbiol 1985;22:405–8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [18].Wolf AA, Jobling MG, Saslowsky DE, Kern E, Drake KR, Kenworthy AK, et al. Attenuated endocytosis and toxicity of a mutant cholera toxin with decreased ability to cluster ganglioside GM1 molecules. Infect Immun 2008;76:1476–84. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [19].Cardeno A, Magnusson MK, Quiding-Jarbrink M, Lundgren A. Activated T follicular helper-like cells are released into blood after oral vaccination and correlate with vaccine specific mucosal B-cell memory. Sci Rep 2018;8:2729. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [20].Gaines H, Andersson L, Biberfeld G. A new method for measuring lymphoproliferation at the single-cell level in whole blood cultures by flow cytometry. J Immunol Methods 1996;195:63–72. [DOI] [PubMed] [Google Scholar]
- [21].Svahn A, Linde A, Thorstensson R, Karlen K, Andersson L, Gaines H. Development and evaluation of a flow-cytometric assay of specific cell-mediated immune response in activated whole blood for the detection of cell-mediated immunity against varicella-zoster virus. J Immunol Methods 2003;277:17–25. [DOI] [PubMed] [Google Scholar]
- [22].Arifuzzaman M, Rashu R, Leung DT, Hosen MI, Bhuiyan TR, Bhuiyan MS, et al. Antigen-specific memory T cell responses after vaccination with an oral killed cholera vaccine in Bangladeshi children and comparison to responses in patients with naturally acquired cholera. Clin Vaccine Immunol 2012;19:1304–11. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [23].Alam MM, Riyadh MA, Fatema K, Rahman MA, Akhtar N, Ahmed T, et al. Antigen-specific memory B-cell responses in Bangladeshi adults after one- or two-dose oral killed cholera vaccination and comparison with responses in patients with naturally acquired cholera. Clin Vaccine Immunol 2011;18:844–50. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [24].Crotty S, Aubert RD, Glidewell J, Ahmed R. Tracking human antigen-specific memory B cells: a sensitive and generalized ELISPOT system. J Immunol Methods 2004;286:111–22. [DOI] [PubMed] [Google Scholar]
- [25].Levine MM, Black RE, Clements ML, Cisneros L, Nalin DR, Young CR. Duration of infection-derived immunity to cholera. J Infect Dis 1981;143:818–20. [DOI] [PubMed] [Google Scholar]
- [26].Allen CD, Okada T, Cyster JG. Germinal-center organization and cellular dynamics. Immunity 2007;27:190–202. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [27].Breitfeld D, Ohl L, Kremmer E, Ellwart J, Sallusto F, Lipp M, et al. Follicular B helper T cells express CXC chemokine receptor 5, localize to B cell follicles, and support immunoglobulin production. J Exp Med 2000;192:1545–52. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [28].Campbell DJ, Kim CH, Butcher EC. Separable effector T cell populations specialized for B cell help or tissue inflammation. Nat Immunol 2001;2:876–81. [DOI] [PubMed] [Google Scholar]
- [29].Fazilleau N, McHeyzer-Williams LJ, Rosen H, McHeyzer-Williams MG. The function of follicular helper T cells is regulated by the strength of T cell antigen receptor binding. Nat Immunol 2009;10:375–84. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [30].Kim CH, Rott L, Kunkel EJ, Genovese MC, Andrew DP, Wu L, et al. Rules of chemokine receptor association with T cell polarization in vivo. J Clin Invest 2001;108:1331–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [31].Forster R, Schubel A, Breitfeld D, Kremmer E, Renner-Muller I, Wolf E, et al. CCR7 coordinates the primary immune response by establishing functional microenvironments in secondary lymphoid organs. Cell 1999;99:23–33. [DOI] [PubMed] [Google Scholar]
- [32].Hardtke S, Ohl L, Forster R. Balanced expression of CXCR5 and CCR7 on follicular T helper cells determines their transient positioning to lymph node follicles and is essential for efficient B-cell help. Blood 2005;106:1924–31. [DOI] [PubMed] [Google Scholar]
- [33].Reif K, Ekland EH, Ohl L, Nakano H, Lipp M, Forster R, et al. Balanced responsiveness to chemoattractants from adjacent zones determines B-cell position. Nature 2002;416:94–9. [DOI] [PubMed] [Google Scholar]
- [34].Aversa G, Punnonen J, Carballido JM, Cocks BG, de Vries JE. CD40 ligand-CD40 interaction in Ig isotype switching in mature and immature human B cells. Semin Immunol 1994;6:295–301. [DOI] [PubMed] [Google Scholar]
- [35].Garside P, Ingulli E, Merica RR, Johnson JG, Noelle RJ, Jenkins MK. Visualization of specific B and T lymphocyte interactions in the lymph node. Science 1998;281:96–9. [DOI] [PubMed] [Google Scholar]
- [36].Fuleihan R, Ramesh N, Geha RS. Role of CD40-CD40-ligand interaction in Ig-isotype switching. Curr Opin Immunol 1993;5:963–7. [DOI] [PubMed] [Google Scholar]
- [37].van Zelm MC, Bartol SJ, Driessen GJ, Mascart F, Reisli I, Franco JL, et al. Human CD19 and CD40L deficiencies impair antibody selection and differentially affect somatic hypermutation. J Allergy Clin Immunol 2014;134:135–44. [DOI] [PubMed] [Google Scholar]
- [38].Forster R, Emrich T, Kremmer E, Lipp M. Expression of the G-protein--coupled receptor BLR1 defines mature, recirculating B cells and a subset of T-helper memory cells. Blood 1994;84:830–40. [PubMed] [Google Scholar]
- [39].Han S, Hathcock K, Zheng B, Kepler TB, Hodes R, Kelsoe G. Cellular interaction in germinal centers. Roles of CD40 ligand and B7–2 in established germinal centers. J Immunol 1995;155:556–67. [PubMed] [Google Scholar]
- [40].Renshaw BR, Fanslow WC 3rd, Armitage RJ, Campbell KA, Liggitt D, Wright B, et al. Humoral immune responses in CD40 ligand-deficient mice . J Exp Med 1994;180:1889–900. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [41].Rahman A, Rashu R, Bhuiyan TR, Chowdhury F, Khan AI, Islam K, et al. Antibody-secreting cell responses after Vibrio cholerae O1 infection and oral cholera vaccination in adults in Bangladesh. Clin Vaccine Immunol 2013;20:1592–8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [42].Kauffman RC, Bhuiyan TR, Nakajima R, Mayo-Smith LM, Rashu R, Hoq MR, et al. Single-Cell Analysis of the Plasmablast Response to Vibrio cholerae Demonstrates Expansion of Cross-Reactive Memory B Cells. MBio 2016;7. [DOI] [PMC free article] [PubMed]
- [43].Ebert LM, Schaerli P, Moser B. Chemokine-mediated control of T cell traffic in lymphoid and peripheral tissues. Mol Immunol 2005;42:799–809. [DOI] [PubMed] [Google Scholar]
- [44].Holmgren J, Parashar UD, Plotkin S, Louis J, Ng SP, Desauziers E, et al. Correlates of protection for enteric vaccines. Vaccine 2017;35:3355–63. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [45].Lycke NY, Bemark M. The role of Peyer’s patches in synchronizing gut IgA responses. Front Immunol 2012;3:329. [DOI] [PMC free article] [PubMed] [Google Scholar]
- [46].Leung DT, Uddin T, Xu P, Aktar A, Johnson RA, Rahman MA, et al. Immune responses to the O-specific polysaccharide antigen in children who received a killed oral cholera vaccine compared to responses following natural cholera infection in Bangladesh. Clin Vaccine Immunol 2013;20:780–8. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.